Almond supplementation for 12 wk significantly improved blood pressure and lipid profile in pregnant women with hypertension and dyslipidemia.
Daily Almond Supplementation Improves Blood Pressure and Lipid Profile in Pregnant Women with Hypertension and Dyslipidemia: A Randomized Controlled Trial.
AI Summary
Key Findings
Abstract
BACKGROUND: Hypertension and dyslipidemia during pregnancy increase risk of adverse maternal and fetal outcomes. Although almond supplementation is recognized for its cardioprotective effects in nonpregnant populations, its role during pregnancy remains underexplored despite its potential as a safe and accessible dietary intervention. OBJECTIVES: To evaluate the effects of almond supplementation at 2 doses (10 g/d and 25 g/d) on blood pressure, lipid profile, and heart rate in pregnant women with hypertension and dyslipidemia. METHODS: This single-center, 12-wk randomized controlled trial enrolled 103 pregnant women (≥20 wk of gestation) with confirmed hypertension and/or dyslipidemia from Aga Khan Maternity Hospital, Karachi, with 46 participants meeting criteria for both conditions included in the primary analysis. Participants were randomly assigned into 3 groups: no-intervention (NI, control), 10 g/d almonds (A10), or 25 g/d almonds (A25). Primary outcomes were changes in systolic and diastolic blood pressure, measured every 4 wk. Secondary outcomes included serum triglycerides (TG), total cholesterol (TC), LDL, HDL, and heart rate, assessed at baseline and week 12. Data were analyzed using 1-way and 2-way repeated-measures analysis of variance with post hoc testing (P≤0.05 considered significant). RESULTS: At week 12, systolic blood pressure and diastolic blood pressure decreased significantly in both A10 (-13.7% and -5.8%) and A25 (-18.3% and -7.9%) compared with NI (-7.4% and -1.6%; P
Affiliation
Jamshed Arslan
External References
- PubMed ID:
- 41456674
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.